Cynapsus Therapeutics Inc. — Form D/A

Cynapsus Therapeutics Inc. of TORONTO, A6, a company, filed a Form D amendment with the SEC on 2011-11-18. The offering totals $389K, of which $389K was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
Ilan OrenDirectorMorrisville, NC
Nathan BrysonExecutive OfficerMorristown, NJ
DAVID HILLDirectorCharlotte, NC
Andrew WilliamsExecutive OfficerHuntington Beach, CA
Julia LevyDirectorAuburn, WA
Anthony GiovinazzoDirectorMississauga, A6
Anthony GiovinazzoExecutive OfficerMississauga, A6
Perry MolinoffDirectorDALLAS, TX
Margaret Nan HutchinsonDirectorToronto, A6
Thierry D BilbaultExecutive OfficerToronto, A6
Tamar D HowsonDirectorToronto, A6
Ronald HoskingDirectorToronto, A6
Rochelle D StenzlerDirectorToronto, A6
Ilan Nan OrenDirectorToronto, A6
Tomer GoldDirectorToronto, A6
Perry Nan MolinoffDirectorToronto, A6
Nan HutchinsonDirectorToronto, A6
Rochelle D C StenzlerDirectorToronto, A6
Alan D C RyleyDirectorToronto, A6
Alan D C TorrieDirectorToronto, A6
Alan TorrieDirectorTORONTO, A6
Alan RyleyDirectorTORONTO, A6
Rochelle StenzlerDirectorTORONTO, A6

Other filings by this issuer (9)

FiledFormOfferingSold
2015-04-14D$16.8M$16.8M
2014-04-21D$42.9M$14.5M
2013-03-27D/A$13.0M$4.1M
2013-03-20D$2.4M
2013-03-15D$11.2M$3.9M
2012-03-28D/A$940K$940K
2012-01-09D/A$762K$762K
2011-12-28D/A$555K$555K
2011-10-13D$222K$222K

More